Factors determining final height in congenital adrenal hyperplasia

Journal of Pediatric Endocrinology and Metabolism

Volumn 14, Issue SUPPL. 2, 2001, Pages 933-937

  New, M I ^a  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

21 Hydroxylase deficiency; Congenital adrenal hyperplasia; GnRH; Growth hormone; Short stature

Indexed keywords

ANDROGEN; GLUCOCORTICOID; GONADORELIN AGONIST; GONADORELIN DERIVATIVE; GROWTH HORMONE; HORMONE PRECURSOR; HYDROCORTISONE; STEROID 21 MONOOXYGENASE;

ADRENAL DISEASE; ARTICLE; BODY HEIGHT; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONGENITAL ADRENAL HYPERPLASIA; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HORMONE SUBSTITUTION; HORMONE SYNTHESIS; HUMAN; MALE; PERINATAL PERIOD; PREDICTION; PRENATAL PERIOD; SHORT STATURE; STEROID 21 MONOOXYGENASE DEFICIENCY; TREATMENT OUTCOME; VIRILIZATION;

EID: 0034888448     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/jpem-2001-s204     Document Type: Article

References (17)

1. Congenital adrenal hyperplasia: Update on prenatal diagnosis and treatment
2. Adult height and fertility in men with congenital virilizing adrenal hyperplasia
3. Adrenal hyperplasia in intersex states
4. Benign testicular tumors in children with congenital adrenal hyperplasia
5. Longer term outcome in females with congenital adrenal hyperplasia (CAH): The Cardiff experience
6. An attenuated form of congenital virilizing adrenal hyperplasia
7. Genetic defects of steroidogenesis in premature pubarche
8. Close genetic linkage between HLA and congenital adrenal hyperplasia (21-hydroxylase deficiency)
9. Frequent deletion and duplication of the steroid 21-hydroxylase genes
10. Deletion of the steroid 21-hydroxylase and complement C4 genes in congenital adrenal hyperplasia
11. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: Newborn screening and its relationship to the diagnosis and treatment of the disorder
12. Excess mineralocorticoid receptor activity in patients with dexamethasone-suppressible hyperaldosteronism is under adrenocorticotropin control
13. The effect of treatment of final height in classical congenital adrenal hyperplasia (CAH)
14. Congenital adrenal hyperplasia and precocious gonadotropin secretion in a 6 year old girl
15. Final height in 69 patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
16. Dexamethasone treatment of virilizing congenital adrenal hyperplasia: The ability to achieve normal growth
17. Growth hormone therapy alone or in combination with gonadotropin-releasing hormone analog therapy to improve the height deficit in children with congenital adrenal hyperplasia